Healthcare -
Biotechnology - NASDAQ - US
$ 4.41
-2.65 %
$ 204 M
Market Cap
-1.55
P/E
FDMT - STOCK-BASED COMPENSATION
Stock-based Compensation FDMT - 4D Molecular Therapeutics, Inc.
19.7 M
LAST VALUE
19.38%
2 YEAR CAGR
70.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR